Search Results
What EMERALD Phase III trial could mean for breast cancer patients | Virginia Kaklamani, MD
The Emerald Trial | Virginia Kaklamani, MD
EMERALD lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Virginia Kaklamani
Genomic testing Emerald Trial Video
The predictive value of treatment response after neoadjuvant therapy
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Top 5 facts Video Emerald Trial Video
EMERALD Study lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Aditya Bardia
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Understanding Progression: How to Identify and Treat ESR1 Mutations in HR+ MBC
ABCF | Hot Topic Mentor Session Dec. 9.
Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast Cancer
